题目： Functional Genomics and Precision Medicine for Cancer Drug Discovery
报 告 人： Zhizhong Li，Ph.D. （Investigator, Genomics Institute of the Novartis Research Foundation, San Diego）
报告时间：2015年10月29日下午15:00
报告地点：杏鑫平台江湾校区生科院楼B303会议室
报告人简介🥬：
- 2013- Investigator, Genomics Institute of the Novartis Research Foundation
- 2010-2013 Presidential Postdoc Fellow, Novartis Institutes for Biomedical Research
- 2009-2010 Postdoc Fellow, Radiation Oncology, Duke University
- 2005-2009 Ph.D.in Cancer Biology, Duke University
- 2001-2005 B. S. in Biological Science and Biotechnology, Tsinghua University
Research Interests:
High throughput genetic and drug combination screening in cancer and stem cells; Non-coding RNAs🧜🏼🙇🏻♂️，发表研究论文20余篇🧖🏼，5年引用近3000次👩🏽✈️；以笔名“菠萝”写作癌症科普系列🚣🏽♂️，网上阅读超过一千万，被誉为“中国最好的癌症深度科普”，出版科普书籍“癌症真相”🙍🏽♂️。
Most Significant Publications:
- Gong C *, Li Z *, et al., A Long Non-coding RNA, LncMyoD, Regulates Skeletal Muscle Differentiation by Blocking IMP2-Mediated mRNA Translation. Developmental Cell. 2015 ,
- Li Z Zhang Y. et,al. Oncogenic NRAS, Required for Pathogenesis of Embryonic Rhabdomyosarcoma, Relies upon the HMGA2–IGF2BP2 Pathway. Cancer Research. 2013
- Li Z, Gilbert JA, Zhang Y. et,al. An HMGA2-IGF2BP2 axis regulates myoblast proliferation and myogenesis. Developmental Cell. 2012
- Li Z, Rich JN. et, al. Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioblastoma Stem Cells. Cancer Cell. 2009 (Cover Story)
- Li Z（菠萝）👌🏻，癌症科普书《癌症.真相》，清华大学出版社，2015